15 Best Growth Stocks to Invest in for the Next 5 Years

Page 13 of 13

1. Atossa Therapeutics, Inc. (NASDAQ:ATOS)

Upside potential as of June 24, 2025: 594.83%

Ascendiant Capital analysts slightly increased the price target for Atossa Therapeutics, Inc. (NASDAQ:ATOS) to $7.50, up from $7.25, with an unchanged Buy rating. This potential surge of 837% from current levels reinforces the company’s attractive valuation.

In making their judgment, the analysts noted that the updated price target is the perfect balance between the company’s high risks and its growth prospects. While analyzing the net present value of Atossa Therapeutics, Inc. (NASDAQ:ATOS), the firm pointed towards the company’s impressive liquidity position with a current ratio of 12.67. This is anything but ordinary.

Despite its associated risks, Atossa Therapeutics, Inc. (NASDAQ:ATOS) exhibits high upside opportunities. Just recently, the company highlighted its strategic moves in breast cancer at the Jefferies Conference. While utilizing Generative AI, Atossa Therapeutics will discover effective drug combinations, along with efforts to capitalize on the multi-billion-dollar market for estrogen receptor-positive breast cancer with Z endoxifen.

Atossa Therapeutics, Inc. (NASDAQ:ATOS) is a Washington-based clinical-stage biopharmaceutical company focused on developing medicines for women’s breast cancer and other oncological conditions. Founded in 2008, the company aims to transform breast cancer treatment through innovative and tailored solutions.

While we acknowledge the potential of ATOS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ATOS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.

Page 13 of 13